Skip to navigation Skip to content



National MS Society Testifies on Critical Need for Prescription Drug Reform Before Senate Finance Committee

March 15, 2022

The National Multiple Sclerosis Society’s Vice President of Advocacy, Steffany Stern, will testify on Wednesday, March 16 on Capitol Hill before the Senate Finance Committee as a witness at the hearing “Prescription Drug Price Inflation: An Urgent Need to Lower Drug Prices in Medicare”. The hearing will livestream at 10 a.m. (EST) on the Committee’s website. The Society continues to be the leading patient advocacy group raising awareness on the effect of the high cost of MS disease modifying therapies (DMTs) on people living with MS.   
Stern, whose mother lives with MS, will describe her challenges with affording her medications, share the experiences of other people with MS and advocate for potential solutions. “It is unconscionable that in 2022, people with MS and other health conditions who cannot pay for their medications would be in the same position my mom was during the 1980s - with no treatment option,” Stern shares.  
The full written testimony will be available online on the Senate Finance Committee’s website after the hearing concludes.   
The Society believes that medications can only changes lives if people can access them, and those medications and the process for getting them must be affordable, simple and transparent. The Society has established comprehensive policy recommendations on how the Congress and the healthcare system can improve the affordability and accessibility of MS medications since 2016. 

The following witnesses will offer additional testimony at the hearing:  
  • Rena M. Conti, Ph.D., Associate Professor, Markets, Public Policy and Law, Questrom School of Business, Boston University 
  • Douglas Holtz-Eakin, Ph.D., President, American Action Forum 
  • Stephen Ezell, Vice President, Global Innovation Policy, Information Technology and Innovation Foundation 
UPDATE: Watch Steffany Stern testify HERE

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system. Symptoms range from numbness and tingling to blindness and paralysis, and there is currently no cure for MS. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. An estimated 1 million people live with MS in the United States. Most people with MS are diagnosed between the ages of 20 and 50, and it affects women three times more than men.


© 2023 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.